N
Newbury Pharmaceuticals AB
STO:NEWBRY
Newbury Pharmaceuticals AB
STO:NEWBRY
Price:
1.085
SEK
Market Closed
Market Cap:
kr33m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Newbury Pharmaceuticals AB
STO:NEWBRY
|
SE |
|
Q
|
Quality Power Electrical Equipments Ltd
NSE:QPOWER
|
IN |
|
C
|
Changsha DIALINE New Material Sci & Tech Co Ltd
SZSE:300700
|
CN |
|
B
|
Broad Enterprise Co Ltd
TSE:4415
|
JP |
|
K
|
Kandal M Venture Ltd
NASDAQ:FMFC
|
KH |
|
Eros Resources Corp
XTSX:ERC
|
CA |
|
A
|
Asian Insulators PCL
SET:AI
|
TH |
Multiples-Based Value
The Multiples-Based Value for Newbury Pharmaceuticals AB (NEWBRY) under the Base Case is hidden SEK. Compared with the current market price of 1.085 SEK, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NEWBRY Multiples-Based Value
LOCKED
Multiples Across Competitors
NEWBRY Competitors Multiples
Newbury Pharmaceuticals AB Competitors
Newbury Pharmaceuticals AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
N
|
Newbury Pharmaceuticals AB
STO:NEWBRY
|
33m SEK | 0.9 | -1.3 | -1.1 | -1.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 14 | 44.2 | 29.8 | 31.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.6 | 17.7 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
